Published: 05-Jun-2020 | Published By: Market Research Store
AstraZeneca, the drug company, has decided to manufacture the potential vaccine for COVID-19.
Pascal Soriot confirmed that the trials of the drug are under way and the firm now needs to make doses in order to meet the demand in case the vaccine proves successful.
In the statement he confirmed that they have planned to manufacture the vaccine so that by the time results are out they have them to use it.
AstraZeneca has made the statement that they will be able to supply two billion doses of the vaccine.
Furthermore, Mr. Soriot also commented that manufacturing of the vaccine has started since they want it to be fast. He also added that the decision made by them is risky in terms of finance if the results for the vaccine are negative. This will cause the wastage of both the raw materials and the vaccines that are manufactured.
He said that at this bad time, AstraZeneca is not seeking to make a profit by manufacturing the vaccine.
If all goes well then the company will be able to manufacture two billion doses after signing two new contracts one will be with the Bill Gates.
AstraZeneca along with the scientists at Oxford University are developing the vaccine have made an agreement that half of the doses will be supplied to the middle and low-income countries around the world.
Serum Institute of India (SII), which is the largest manufacturer of vaccines by volume globally, is one of the new partnerships. The other is a $750m (£595m) deal with two health organizations backed by Melinda and Bill Gates.
The Coalition for Epidemic Preparedness Innovations (CEPI) and GAVI vaccines alliance are two charity organizations that are going to help find production facilities for the production and distribution of the 300 million vaccine doses. The vaccine delivery is expected by the end of the year.
Knowing the importance of how vaccines are important to save several lives Market Research Store has published a report on the global vaccines market which showcases the importance of the vaccines industry.
Medical QMS Software-United States Market Status and Trend Report 2020-2025
Medical QMS Software-India Market Status and Trend Report 2020-2025
Medical QMS Software-China Market Status and Trend Report 2020-2025
Medical QMS Software-Asia Pacific Market Status and Trend Report 2020-2025
Medical QMS Software-EMEA Market Status and Trend Report 2020-2025View More
Rheumatic Disease Diagnosis Move to the Era of Precision Medicine
Rheumatic conditions in many of the cases develop slowly and the initial symptom is inflammatory a
Again Threat of Pandemic as New Swine Flu Strain Found
Evidence of a new strain of swine flu, which may lead to another pandemic hit, has been found by g
The Treatment for Schizophrenia Gets Improved Due to Improved Way of Analyzing fMRI Data
University of Marylands researchers have introduced new tools that have improved the analysis of f
Cravings for Sugar can be Beat by Plant Compound
Millions of people are stuck at their houses owing to the outbreak of COVID-19, thus many of them
To Study the Cannabis Impact on Oral Health, Researches Receive $1.5 Million Grant
The Canadian Institutes of Health Research have presented a five year, $1.5 million grant to the U